Johnson & Johnson (NYSE:JNJ) is making the unusual move of hiring an outside firm to manage the recall of its DePuy ASR hip implant, a decision that could limit its financial exposure – and limit patients’ access to replacement devices.
The New Brunswick, N.J.-based medical and consumer products conglomerate tapped Broadspire Services Inc. to handle patient claims associated with the recall. Companies typically handle such things in-house, accepting the judgment of physicians about whether a revision surgery is necessary.